Structure, Function and Inhibition of Poly(ADP-ribose)polymerase, Member 14 (PARP14)

E-ISSN： 1875-5607|18|19|1659-1669

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.18, Iss.19, 2018-11, pp. : 1659-1669

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Poly(ADP-ribose)polymerase Inhibition - Where Now?

Current Medicinal Chemistry, Vol. 12, Iss. 20, 2005-09 ,pp. : 2373-2392

Bentham Science Publishers

Access to resources Recommend Favorite

New inhibitors of poly(ADP-ribose) polymerase (PARP)

By Peukert Stefan Schwahn Uwe

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 11, 2004-11 ,pp. : 1531-1551

Informa Healthcare

Access to resources Recommend Favorite

Current Overview on the Usage of Poly(ADP-ribose)polymerase (PARP) Inhibitors in Treating Cancer

Clinical Cancer Drugs, Vol. 1, Iss. 2, 2014-01 ,pp. : 127-148

Bentham Science Publishers

Access to resources Recommend Favorite

Current Overview on the Usage of Poly(ADP-ribose)polymerase (PARP) Inhibitors in Treating Cancer

Clinical Cancer Drugs, Vol. 1, Iss. 2, 2014-05 ,pp. : 127-148

Bentham Science Publishers

Access to resources Recommend Favorite

Poly (ADP-Ribose) Polymerase-1 (PARP-1) as Immune Regulator

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 11, Iss. 4, 2011-12 ,pp. : 326-333

Bentham Science Publishers

Access to resources Recommend Favorite